Category Alzheimer’s

When cognitive test scores are skewed by education, language, or depression, blood biomarkers, PET imaging, functional assessment, and alternative tests offer reliable paths to Alzheimer's diagnosis.

Memantine slows cognitive decline in moderate-to-severe Alzheimer's when taken correctly and tolerated well, but ask your prescriber about drug interactions and realistic timelines first.

Continuing Alzheimer's medications in moderate-to-severe disease is evidence-based when they support functional goals; disease stage alone should not determine treatment decisions.

Learn which donepezil side effects need urgent care, which questions to ask, and how to plan a supervised medication review.

Learn what to do after missed donepezil doses, when seven days changes the plan, and which symptoms need prompt care.

Learn how Aricept and generic donepezil compare, which side effects to watch for, and when dose changes need medical guidance.

Donepezil and memantine produce different side-effect patterns, so symptom timing, dose, kidney health, and heart risks matter.

A late symptom may be linked to donepezil, a dose increase, another medicine, or dementia itself, so timing needs careful review.

Learn when donepezil and ibuprofen need medical review, what the evidence can and cannot prove, and which symptoms require prompt care.

A pharmacist can identify opposing drug effects, cognitive risks, retention concerns, and safer questions for the prescribing team.